Posterior Circulation Stroke Jessica Heckenberger BSN RN - PowerPoint PPT Presentation

1 / 43
About This Presentation
Title:

Posterior Circulation Stroke Jessica Heckenberger BSN RN

Description:

Posterior Circulation Stroke Jessica Heckenberger BSN RN 1 Diagnostic Work-up Diagnostic work-up done to: Determine etiology of stroke Identify risk factors Determine ... – PowerPoint PPT presentation

Number of Views:214
Avg rating:3.0/5.0
Slides: 44
Provided by: Kle134
Category:

less

Transcript and Presenter's Notes

Title: Posterior Circulation Stroke Jessica Heckenberger BSN RN


1
Posterior Circulation StrokeJessica Heckenberger
BSN RN
2
Stroke Statistics
  • Stroke is the 5th leading cause of death in the
    U.S.
  • Stroke kills almost 130,000 Americans each
    yearthats 1 out of every 19 deaths.
  • On average, one American dies from stroke every 4
    minutes.
  • Stroke costs the United States an estimated 38.6
    billion each year. This total includes the cost
    of health care services, medications to treat
    stroke, and missed days of work.

3
F.A.S.T.
  • F-Face Drooping Does one side of the face droop
    or is it numb? Ask the person to smile. Is the
    person's smile uneven?
  • A- Arm-Is one arm weak or numb? Ask the person to
    raise both arms. Does one arm drift downward?
  • S-Speech Difficulty Is speech slurred? Is the
    person unable to speak or hard to understand? Ask
    the person to repeat a simple sentence, like "The
    sky is blue." Is the sentence repeated correctly?
  • T-Time-What was the time the person was last
    known well?

4
Beyond Fast B.E. F.A.S.T
  • B-Balance-Sudden trouble walking, dizziness, loss
    of balance or coordination
  • E-Eyes-Sudden trouble seeing in one or both eyes

Vision
5
St. Lukes Primary Stroke Centers
  • St. Lukes Allentown Campus
  • St. Lukes Anderson Campus
  • St. Lukes Bethlehem Campus

6
Posterior Circulation Stroke
  • Posterior circulation stroke accounts for 20-25
    of ischemic strokes
  • Specialist assessment and administration of
    intravenous tissue plasminogen activator are
    delayed in posterior circulation stroke compared
    with anterior circulation stroke
  • Basilar occlusion is associated with high
    mortality or severe disability, especially if
    blood flow is not restored in the vessel if
    symptoms such as acute coma, dysarthria,
    dysphagia, quadriparesis, pupillary and
    oculomotor abnormalities are detected, urgently
    seek the input of a stroke specialist

7
The Posterior Circulation
  • Vertebral arteries
  • The basilar artery
  • The posterior cerebral arteries and their
    branches

8
PCA Supply
  • Posterior Circulation Brain Structures
  • Brainstem (medulla, pons, and midbrain)
  • Cerebellum
  • Thalamus
  • Hippocampus
  • Areas of temporal and occipital cortex

9
Etiology
  • Arterial atherosclerosis (large artery disease)
    and penetrating artery disease (lacunes).
  • Cardiogenic embolization is more common than
    previously suspected and is responsible for
    20-50 of posterior circulation strokes
  • Vascular obstruction or occlusion is the
    fundamental disorder leading to hypoperfusion

10
Time is Brain
11
Risk Factors
  • Uncontrollable Risk Factors
  • Age
  • Gender
  • Race
  • Family history of stroke or TIA
  • Personal history of diabetes

12
Risk Factors
  • Medical Risk Factors
  • Hypertension
  • Heart disease (such as atrial fibrillation or
    left ventricular hypertrophy)
  • Previous stroke or TIA
  • Previous heart surgery
  • Carotid artery disease
  • Peripheral vascular disease
  • Smoking

13
Signs and Symptoms
  • 5 Ds
  • Dizziness
  • Diplopia
  • Dysarthria
  • Dysphagia
  • Dystaxia

14
Signs and Symptoms
  • Changes in eye movement-
  • Visual field loss in one or both
  • eyes.
  • Ptosis
  • Diplopia

15
Signs and Symptoms
  • Dizziness/Vertigo
  • Symptoms ranging from near-syncope,
    lightheadedness or faintness to a sensation of
    movement or disequilibrium, unsteadiness, or
    imbalance
  • Vertigo with or without nausea and vomiting

16
Signs and Symptoms
  • Dysphagia or dysarthria
  • Crossed syndromes, consisting of ipsilateral
    cranial nerve dysfunction and contralateral long
    motor or sensory tract dysfunction are highly
    characteristic of posterior circulation stroke
  • Sensory deficits (numbness, including loss of
    sensation or par aesthesia in any combination of
    extremities, sometimes including all four limbs
    or both sides of the face or mouth)
  • Isolated reduced level of consciousness is not a
    typical stroke symptom but can result from
    bilateral thalamic or brainstem ischemia

17
Posterior Circulation Infarction According to
Anatomical Location and Vascular Territory
Affected
  • Lateral medulla (intracranial vertebral artery
    infarct, also known as Wallenberg syndrome)
  • Nystagmus, vertigo, ipsilateral Horners
    syndrome, ipsilateral facial sensory loss,
    dysarthria, hoarseness, and dysphagia
  • Contralateral hemisensory loss in the trunk and
    limbpain and temperature
  • Medial medulla
  • Ipsilateral tongue weakness and later hemiatrophy
    of the tongue
  • Contralateral hemiparesis of the arm and leg
  • Hemisensory losstouch and proprioception
  • Pons
  • Hemiparesis or hemisensory loss, ataxic
    hemiparesis, dysarthria, horizontal gaze palsy
  • Complete infarction causes locked-in syndrome
    with quadriparesis, loss of speech, but preserved
    awareness and cognition, and sometimes preserved
    eye movements

18
Locked-in Syndrome
  • Locked-in Syndrome (LIS) results from a lesion to
    the brainstem, most frequently an ischemic
    pontine lesion. It results in severe impairments
    due to the complete disruption of the motor
    pathways controlling eyes, face, trunk and limb
    movements, including breathing, swallowing and
    phonation. However consciousness and cortical
    functions are preserved.
  • LIS is defined as a syndrome characterized by
    preserved awareness, relatively intact cognitive
    functions, and by the ability to communicate
    while being paralyzed and voiceless.

19
Locked-in Syndrome
  • Locked-in syndrome affects around 1 of people
    who have as stroke
  • Individuals with LIS have the highest level of
    disability among stroke survivors
  • It is a condition for which there is no treatment
    or cure, and it is extremely rare for patients to
    recover any significant motor functions.
  • 90 die within four months of its onset
  • Initial stroke primary cause of death (25 of
    cases)
  • Voluntary cough is often impossible, and
    sometimes there is no reflex cough
  • Aspiration pneumonias are more common during the
    acute phase
  • Secondarily to infections such as pneumonia (40
    of cases)

20
Locked-in Syndrome
  • Acute Phase
  • Respiratory tract monitoring and cardiovascular
    support
  • Thrombolysis or the prescription of blood
    thinners based on the type of vascular impairment
  • Peg tube feeding
  • Tracheostomy
  • VTE prophylaxis
  • Skin care management
  • PT
  • ROM
  • Bracing
  • Proper posturing in bed

21
Locked-In Syndrome
  • Rehabilitation Phase
  • Individuals use eye movements to communicate
  • Communication devices (as computer with synthetic
    voice)
  • Some individuals may be suitable for weaning from
    their tracheostomy as their condition improves
    during the first months
  • Exercises to maintain range of motion, as well as
    breathing, eyes, head, trunk and limb control
    exercises are performed throughout the
    rehabilitation process.

22
Diagnosing
  • History and physical exam
  • Horners syndrome- ptosis, small pupil, and
    anhydrosis on the same side, bilateral small or
    fixed pupils, and ataxia may aid early diagnosis.
  • Non-contrast CT of head
  • CT angiography- identify basilar artery occlusion
  • MRI

23
Management
  • Thrombolysis
  • Intra-arterial thrombolytic therapy
  • Heparin Therapy
  • Neurosurgery

24
tPA (Activase)
  • Tissue plasminogen activator.
  • Activase is indicated for the management of acute
    ischemic stroke in adults for improving
    neurological recovery and reducing the incidence
    of disability

25
Rationale for Use
  • Limit size of infarct by dissolving clot
    restoring blood flow to ischemic brain.
  • Prompt treatment with (t-PA) may promote
    reperfusion and improve functional outcomes for
    patient.

26
Time Frame
  • Given intravenously within 3 hours of acute
    ischemic stroke (FDA)
  • The window can be extended to 4.5 hours if
    patient meets additional criteria
  • Goal Door to Needle Time
  • Administer (t-PA) within 1 hour of arrival to
    hospital

27
Effects of tPA
  • Binds to fibrin in a thrombus and converts
    plasminogen to plasmin which initiates local
    fibrinolysisTips the scale in the other
    direction.
  • Fibrinolysis the breakdown of a blood clot.

28
Effects of tPA
  • Fibrin strand
    Fibrin Strands

Activase (Alteplase)
29
Contraindication 0-3hr Window
  • Evidence of intracranial hemorrhage
  • Suspicion of subarachnoid hemorrhage on
    pretreatment evaluation
  • Recent intracranial or intraspinal surgery,
    serious head trauma, or previous stroke
  • Major surgery / serious trauma
  • History of intracranial hemorrhage
  • Uncontrolled hypertension at time of treatment
    (eg, gt 185 mm Hg systolic or gt 110 mm Hg
    diastolic)
  • Allergy to t-PA
  • Seizure at the onset of stroke (unless
    neuroimaging confirms ischemia)
  • Active internal bleeding
  • Glucose lt 50 or gt 400
  • Known bleeding diathesis including but not
    limited to
  • Current use of oral anticoagulants (eg, warfarin
    sodium) or an International Normalized Ratio
    (INR) gt 1.7or a prothrombin time (PT) gt 15
    seconds
  • Administration of heparin within 48 hours
    preceding the onset of stroke and have an
    elevated activated partial thromboplastin time
    (aPTT) at presentation
  • Platelet count lt 100,000/mm3

30
Contraindications 0 to 4.5 Hour Window
  • CONTRAINDICATIONS - IN ADDITION TO THE 0 TO 3
    HOUR WINDOW
  • Patient age
  • Patient taking oral anticoagulation despite INR
    level
  • History of both stroke and diabetes

31
Risk Factors
  • Largest risk factors is bleeding

32
Benefits of tPA
33
Neurosurgical
  • External ventricular drainage or decompression
    may be lifesaving in large volume cerebellar
    infarction with falling level of consciousness
    attributable to raised intracranial pressure or
    acute hydrocephalus.
  • Emergency posterior fossa decompression with
    partial removal of the infarcted tissue may be
    lifesaving.

34
Diagnostic Work-up
  • Diagnostic work-up done to
  • Determine etiology of stroke
  • Identify risk factors
  • Determine most appropriate secondary stroke
    prophylaxis
  • Anticoagulation
  • Antiplatelet
  • Statins

35
Cardiac Diagnostics
  • Electrocardiogram
  • Look for arrhythmias, conduction problems
  • Transthoracic echocardiogram (TTE)
  • screen for cardioembolic conditions
  • Transesophageal echocardiogram (TEE)
  • Screen for cardioembolic conditions
  • Invasive test

36
Other Diagnostic Studies
  • Carotid Doppler
  • EEG

37
Inpatient Rehabilitation
  • Speech Therapy
  • Physical Therapy
  • Occupational Therapy
  • Dietary Consultation
  • Multidisciplinary Rounds

38
Patient/ Family Education
  • On going education from all disciplines
  • Stroke Patient Education Binder
  • Diagnosis
  • Risk Factors
  • Risk Factor Modification
  • Family Risk
  • Teach S/S of stroke
  • Importance of taking medications
  • Importance of regular medical follow-up
  • Stroke Club

39
Stroke Prevention
  • Hypertension
  • BP lt 120/80 (after acute phase of stroke)
  • Dietary changes, exercise, medications
  • Smoking
  • Cessation counseling
  • Treatment (meds, hypnosis, etc..)
  • Diabetes
  • HgbA1C goal lt 7.0
  • Meds, diet, exercise

40
Prevention Cont.
  • Dyslipidemia
  • Lipid Profile (goals)
  • Total Cholesterol lt 200
  • LDL lt 100 (lt70)
  • HDL gt 35
  • Triglycerides lt 200
  • Meds, diet, exercise
  • Obesity
  • BMI gt 25
  • Exercise for 30 minutes on most days

41
Stroke Data
90th Percentile SLA/B SLA/B SLRA SLRA SLM SLM SLQ SLQ SLW SLW
90th Percentile FY 14 FY 15 YTD FY 14 FY 15 YTD FY 14 FY 15 YTD FY 14 FY 15 YTD FY 14 FY 15 YTD
VTE Prophylaxis 98.65 98.7 100 100 100 100 100 100 100 100 100
Discharge Antithrombotics 98.92 100 100 100 100 100 100 100 100 100 100
Discharge Anticoagulation A. Fib. 94.12 100 100 100 100 100 100 100 100 100 100
Thrombolytic Therapy 89.47 85.7 90 66.7 50 50 ---- ---- ----- 100 ----
Antithrombotic by Day 2 98.53 98.7 100 100 94.7 100 100 100 100 100 100
Discharge Statin 98.15 99.6 99.1 100 100 100 100 95.7 95.7 96.2 96.2
Stroke Education 97.5 99.5 95.9 92 100 77.8 77.8 100 88.9 75 66.7
Rehab Assessment 98.8 100 100 100 100 100 100 100 100 100 100
Door to tPA 60 min 50 68.2 80 50 33.3 0 ---- ----- ----- 0 0
42
  • Thank you
  • And please always remember...

43
References
  • http//brainfoundation.org.au/medical-info/205-loc
    ked-in-syndrome-lis
  • http//cirrie.buffalo.edu/encyclopedia/en/article/
    303/
  • http//www.bmj.com/content/348/bmj.g3175
  • Lewandowski, C., Santhakumar, S., Posterior
    Circulation Stroke, Foundation for Education and
    Research in Neurological Emergencies. 2012.
Write a Comment
User Comments (0)
About PowerShow.com